XML 35 R25.htm IDEA: XBRL DOCUMENT
v3.25.3

SEGMENT REPORTING (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2025
Segment Reporting [Abstract] |
Schedule of Components Optimization Charges | The following table presents the OPTA VIA segment's revenue, significant segment expenses, and segment net income for the three months ended September 30, 2025 and 2024, respectively:
| September 30, 2025 |  | September 30, 2024 |  |
Revenue | $ | 89,409 |  | $ | 140,163 |  |
Less: |  |  |  |  |
Cost of sales | 27,250 |  |  | 34,489 |  |  |
Selling, marketing, and after sales support | 41,543 |  |  | 74,867 |  |  |
Distribution | 3,815 |  |  | 6,138 |  |  |
Technology | 11,123 |  |  | 12,481 |  |  |
Administrative and corporate support functions | 8,849 |  |  | 9,476 |  |  |
Equity compensation | 910 |  |  | 606 |  |  |
Other loss (income) (1) | (1,424) |  | 528 |  |  |
Provision (benefit) for income taxes | (396) |  |  | 449 |  |  |
Segment net income (loss) | $ | (2,261) |  |  | $ | 1,129 |  |  |
Reconciliation of profit or loss |  |  |  |  |
Adjustments and reconciling items | — |  |  | — |  |  |
Consolidated net income (loss) | $ | (2,261) |  |  | $ | 1,129 |  |  |
(1) Other loss (income) included within Segment net income (loss) includes interest income, interest expense, and unrealized gains and losses on LifeMD common stock. The following table presents the OPTA VIA segment's revenue, significant segment expenses, and segment net income for the nine months ended September 30, 2025 and 2024, respectively:
| September 30, 2025 |  | September 30, 2024 |  |
Revenue | $ | 310,692 |  | $ | 483,460 |  |
Less: |  |  |  |  |
Cost of sales | 87,645 |  | 127,056 |  |
Selling, marketing, and after sales support | 151,883 |  | 242,560 |  |
Distribution | 13,646 |  | 32,196 |  |
Technology | 32,731 |  | 38,651 |  |
Administrative and corporate support functions | 25,730 |  | 35,597 |  |
Equity compensation | 5,467 |  | 5,231 |  |
Other income (1) | (7,153) |  | (343) |  |
Provision for income taxes | 1,296 |  | 1,222 |  |
Segment net income | $ | (553) |  |  | $ | 1,290 |  |
Reconciliation of profit or loss |  |  |  |  |
Adjustments and reconciling items | — |  |  | — |  |  |
Consolidated net income (loss) | $ | (553) |  |  | $ | 1,290 |  |
(1) Other income included within Segment net income includes interest income, interest expense, and realized and unrealized gains and losses on LifeMD common stock.

X
- Definition Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 25 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-25 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30 + Details
Name: | us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration